** Shares of surgical equipment maker Teleflex TFX.N fall 11.6% to $157 premarket
** Company forecast 2025 adj profit per share to be between $13.95 and $14.35; analysts had forecast $15.23 per share, according to data compiled by LSEG
** Posts Q4 profit of $3.89 per share vs estimate of $3.86 per share
** Separately, co plans to split into two cos, with urology, acute care and contract manufacturing businesses to be spun off into separate unit
** Co to buy Germany-based Biotronik's blood vessel device unit for about 760 million euros ($796.3 million) in cash to boost Teleflex's core business
** TFX CFO Thomas E. Powell has decided to retire effective April 1
** TFX has fallen 22% in the last 12 months
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.